Shopping Cart 0
Cart Subtotal
USD 0

Veterinary Vaccine Market by Application (Livestock Vaccines and Companion Vaccines), by Technology Types (Attenuated Vaccines, DNA Vaccines, Inactivated Vaccines, Toxoid Vaccines and Recombinant Vaccines) - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 - 2021

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4199

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 6299

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 8399
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

The report covers forecast and analysis for the veterinary vaccine market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the veterinary vaccine market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the veterinary vaccine market on a global level. This report offers comprehensive coverage on global veterinary vaccine market along with, market trends, drivers, and restraints of veterinary vaccine market. This report includes a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porters five forces model for the veterinary vaccine market has also been included. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness. This report is prepared by using data sourced from in-house databases, secondary and primary research team of industry experts. Research analysts and consultants cooperate with leading companies of the concerned domain to verify every value of data exists in this report. The study provides a decisive view on the veterinary vaccine market by segmenting the market based on application, technology, and regions. All these segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The application based market covered under this study includes livestock vaccines and companion vaccines. The technology based market covered under this study includes attenuated vaccines, DNA Vaccines, inactivated vaccines, toxoid vaccines and recombinant vaccines. This report also includes the current and forecast demand for the region of North America, Europe, Asia-Pacific and Latin America. Key operating players for veterinary vaccines market are Heska Corporation, Zoetis Inc., Ceva Sant Animale Inc., Merck Animal Health, Sanofi (Merial Animal Health), Boehringer Ingelheim GmbH, Eli Lilly and Company (Elanco Animal Health), Virbac, and Bayer AG, Bimeda. This report segments the veterinary vaccine market as follows: Veterinary Vaccines Market: Product Segment Analysis Live stock Vaccine Poultry Porcine Aquaculture Companion vaccine Equine Canine Feline Veterinary Vaccines Market: Technology Segment Analysis Attenuated vaccines DNA Vaccines Inactivated vaccines Toxoid vaccines Recombinant vaccines Veterinary Vaccines Market: Geography Segment Analysis North America U.S. Canada Europe France Germany U.K. Asia Pacific India China Thailand Latin America Brazil The Middle East and Africa

READ MORE

Table Of Content

Scope

Chapter1. Introduction 1.1. Report Description And Scope 1.2. Research Scope 1.3. Research Methodology 1.3.1. Market Research Process 1.3.2. Market Research Methodology Chapter2. Executive Summary 2.1. Global veterinary vaccine market, 2015-2021 (USD Billion) 2.2. Global veterinary vaccine market: Snapshot Chapter3. Veterinary vaccine market Market Dynamics 3.1. Introduction 3.2. Value Chain Analysis 3.3. Market Drivers 3.3.1. Global veterinary vaccine market Drivers: Impact Analysis 3.3.2. New emerging technological advances in vaccine development and increasing awareness of animal care 3.3.3. Continuous development of drug resistance by microorganism and new emerging animal diseases 3.4. Market Restraints 3.4.1. Global veterinary vaccine market Restraints: Impact Analysis 3.4.2. High competition 3.5. Opportunities 3.5.1. Increasing investment by government of developing countries. 3.6. Porters Five Forces Analysis 3.6.1. Bargaining Power Of Suppliers 3.6.2. Bargaining Power Of Buyers 3.6.3. Threat From New Entrants 3.6.4. Threat From New Substitutes 3.6.5. Degree Of Competition 3.7. Market Attractiveness Analysis 3.7.1. Market Attractiveness Analysis, by Application segment 3.7.2. Market Attractiveness Analysis, by Technology segment 3.7.3. Market Attractiveness Analysis, By Regional Segment Chapter4. Global veterinary vaccine market Competitive Landscape 4.1. Company Market Share, 2014 (Subject To Data Availability) 4.2. Strategic Development 4.2.1. Acquisitions Mergers 4.2.2. New Source Launch 4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures 4.2.4. Research and Development, Product And Regional Expansion. 4.3. Product Portfolio 4.4. Patent Analysis (2011-2016) 4.4.1. Patent Trend 4.4.2. Patent Share By Company 4.4.3. By Region Chapter5. Global veterinary vaccine market Product type Analysis 5.1. Global veterinary vaccine market: Product type Segment Overview 5.1.1. Global veterinary vaccine market Revenue Share, by Product type Segment, 2015 And 2021 5.2. Livestock vaccines 5.2.1. Global veterinary vaccine market for livestock vaccines , 2015-2021 (USD Billion) 5.3. Companion vaccines 5.3.1. Global veterinary vaccine market for Companion vaccine, 2015-2021 (USD Billion) Chapter6. Global veterinary vaccine market Technology type Analysis 6.1. Global veterinary vaccine market: Technology type Segment Overview 6.1.1. Global veterinary vaccine market Revenue Share, By Technology type Segment, 2015 2021 6.2. Attenuated vaccines 6.2.1. Global veterinary vaccine market for Attenuated vaccines, 2015-2021 (USD Billion) 6.3. DNA Vaccines 6.3.1. Global veterinary vaccine market for DNA vaccines, 2015-2021 (USD Billion) 6.4. Inactivated vaccines 6.4.1. Global veterinary vaccine market for inactivated vaccines, 2015-2021 (USD Billion) 6.5. Toxoid vaccines 6.5.1. Global veterinary vaccine market for toxoid vaccines, 2015-2021 (USD Billion) 6.6. Recombinant vaccines 6.6.1. Global veterinary vaccine market for recombinant vaccines, 2015-2021 (USD Billion) Chapter7. Global veterinary vaccine market Regional Segment Analysis 7.1. Global veterinary vaccine market: Regional Overview 7.1.1. Global veterinary vaccine market Revenue Share, By Region, 2014 And 2020 7.2. North America 7.2.1. North America veterinary vaccine market Revenue, by Product type classification, 2015-2021 , (USD Billion) 7.2.2. North America veterinary vaccine market Revenue, by Technology type 2015-2021 , (USD Billion) 7.2.3. U.S. 7.2.3.1. U.S. veterinary vaccine market revenue, by Product type, 2015-2021 , (USD Billion) 7.2.3.2. U.S. veterinary vaccine market revenue, by Technology type application 2015-2021 , (USD Billion) 7.3. Europe 7.3.1. Europe veterinary vaccine market revenue, by Product type, 2015-2021 (USD Billion) 7.3.2. Europe veterinary vaccine market revenue, by Technology type 2015-2021 , (USD Billion) 7.3.3. U.K. 7.3.3.1. U.K. veterinary vaccine market revenue, by Product type, 2015-2021 , (USD Billion) 7.3.3.2. U.K. veterinary vaccine market Revenue, by Technology type 2015-2021 , (USD Billion) 7.3.4. France 7.3.4.1. U.K. veterinary vaccine market revenue, by Product type, 2015-2021 , (USD Billion) 7.3.4.2. U.K. veterinary vaccine market revenue, by Technology type 2015-2021 , (USD Billion) 7.3.5. Germany 7.3.5.1. Germany veterinary vaccine market revenue, by Product type, 2015-2021 , (USD Billion) 7.3.5.2. Germany veterinary vaccine market revenue, by Technology type 2015-2021 , (USD Billion) 7.4. Asia Pacific 7.4.1. Asia Pacific veterinary vaccine market revenue, by Product type, 2015-2021 (USD Billion) 7.4.2. Asia Pacific veterinary vaccine market revenue, by Technology type Technology type 2015-2021 , (USD Billion) 7.4.3. China 7.4.3.1. China veterinary vaccine market revenue, by Product type, 2015-2021 , (USD Billion) 7.4.3.2. China veterinary vaccine market revenue, by Technology type Technology type 2015-2021 , (USD Billion) 7.4.4. Japan 7.4.4.1. Japan veterinary vaccine market revenue, by Product type, 2015-2021 , (USD Billion) 7.4.4.2. Japan veterinary vaccine market revenue, by Technology type Technology type 2015-2021 , (USD Billion) 7.4.5. India 7.4.5.1. India veterinary vaccine market revenue, by Product type, 2015-2021 , (USD Billion) 7.4.5.2. India veterinary vaccine market revenue, by Technology type Technology type 2015-2021 , (USD Billion) 7.5. Latin America 7.5.1. Latin America Veterinary vaccine market Revenue, by Product type, 2015-2021 (USD Billion) 7.5.2. Latin America veterinary vaccine market revenue, by Technology type Technology type 2015-2021 , (USD Billion) 7.5.3. Brazil 7.5.3.1. Brazil veterinary vaccine market revenue, by Product type, 2015-2021 , (USD Billion) 7.5.3.2. Brazil veterinary vaccine market revenue, by Technology type Technology type 2015-2021 , (USD Billion) Chapter8. Company Profile 8.1. Teva Pharmaceutical Industries Ltd. 8.1.1. Overview 8.1.2. Financials 8.1.3. Product Portfolio 8.1.4. Business Strategy 8.1.5. Recent Developments 8.2. Novartis International AG. 8.2.1. Overview 8.2.2. Financials 8.2.3. Product Portfolio 8.2.4. Business Strategy 8.2.5. Recent Developments 8.3. Mylan N.V. 8.3.1. Overview 8.3.2. Financials 8.3.3. Product Portfolio 8.3.4. Business Strategy 8.3.5. Recent Developments 8.4. Abbott Healthcare Pvt Ltd. 8.4.1. Overview 8.4.2. Financials 8.4.3. Product Portfolio 8.4.4. Business Strategy 8.4.5. Recent Developments 8.5. Actavis pharmaceuticals Overview 8.5.1. Financials 8.5.2. Product Portfolio 8.5.3. Business Strategy 8.5.4. Recent Developments 8.6. Sun Pharmaceutical Industries Limited 8.6.1. Overview 8.6.2. Financials 8.6.3. Product Portfolio 8.6.4. Business Strategy 8.6.5. Recent Developments

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com